Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) SHH

Currency In CNY

AD

Jiangsu Aidea Pharmaceutical Co., Ltd.

Address

No. 2 Liuzhuang Road

Yangzhou, JS 225008

China

Phone

86 514 8753 0666

Sector

Healthcare

Industry

Biotechnology

Employees

735

First IPO Date

July 20, 2020

Key Executives

NameTitlePayYear Born
Jie ZhangChief Executive Officer, President & Director01971
Qide LiDirector of Pharmaceutical Research Institute01981
Tie SunDirector of Pharmacology and Toxicology and Senior Director of Biologics R&D01979
Guang Rong WangVice President & Director01978
Gufang SuDeputy Director of Process R&D01974
Hong QinVice President01981
Jibing ZhangFactory Manager of Human Protein01967
Yu YuanQuality Center Director01980
Gaohong GuSenior Vice President01968
Yan LiuFinancial Director, Secretary & Accounting Supervisor01983
AD

Description

Jiangsu Aidea Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and commercialization of diverse pharmaceutical products. Its extensive offerings encompass a range of medications including folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules. The company also provides pharmaceutical raw materials. Established in 2009, Jiangsu Aidea Pharmaceutical is headquartered in Yangzhou, China.

AD